I-131 metaiodobenzylguanidine therapy
Iodine-131 metaiodobenzylguanidine (I-131 MIBG) is a targeted radioactive therapy for treating neuroendocrine tumors like neuroblastoma and pheochromocytoma.
Iodine-131 metaiodobenzylguanidine (I-131 MIBG) is a targeted radioactive therapy for treating neuroendocrine tumors like neuroblastoma and pheochromocytoma.
Intraoperative gamma probes are crucial in detecting radioactive substances in surgeries, especially in oncology, improving surgical precision and outcomes.
Sentinel Lymph Node Biopsy (SLNB) is a surgical technique used to determine if cancer has spread to the lymphatic system.
Explore the essentials of fluid filtration, covering efficiency, systems, mechanics, and the latest advancements in this comprehensive guide.
Peptide Receptor Radionuclide Therapy (PRRT) is a targeted cancer treatment that combines molecular biology with radiation to treat neuroendocrine tumors.
Molecular radiotherapy is a targeted cancer treatment using radioactive substances to destroy cancer cells with minimal impact on surrounding healthy tissue.
SPECT/CT hybrid imaging combines Single Photon Emission Computed Tomography and Computed Tomography to enhance diagnostic accuracy by integrating functional and anatomical data.
Learn about the V/Q scan, a diagnostic tool used primarily to detect pulmonary embolism by assessing lung air and blood flow.
Comprehensive overview of neuroblastoma imaging techniques, highlighting MRI, CT, MIBG scintigraphy, PET scans, and ultrasonography.
MIBG scintigraphy is a nuclear medicine imaging technique used for detecting cancers derived from nerve tissue.